Shanghai Huilun Pharmaceutical Co., Ltd.
5 clinical trials · Sponsor
◉ Watch Shanghai Huilun Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Abdominal Surgery (NCT07709598) | Shanghai Huilun Pharmaceutical Co., Ltd. | 2026-05-11 |
| Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery (NCT07699601) | Shanghai Huilun Pharmaceutical Co., Ltd. | 2026-05-09 |
| A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia (NCT07146386) | Shanghai Huilun Pharmaceutical Co., Ltd. | 2025-08-01 |
| A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis (NCT06958861) | Shanghai Huilun Pharmaceutical Co., Ltd. | 2025-05-01 |
| The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH (NCT07134907) | Shanghai Huilun Pharmaceutical Co., Ltd. | 2022-07-18 |
Track Shanghai Huilun Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.